An analysis of online content related to testosterone supplementation

References

• Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:2536–2559.
   PubMed Web of Science ®Google Scholar
• Dean JD, McMahon CG, Guay AT, et al. The International Society for Sexual Medicine’s process of care for the assessment and management of testosterone deficiency in adult men. J Sex Med. 2015;12:1660–1686.
   PubMed Web of Science ®Google Scholar
• Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87:589–598.
   PubMed Web of Science ®Google Scholar
• Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86:724–731.
   PubMed Web of Science ®Google Scholar
• Lunenfeld B, Mskhalaya G, Zitzmann M, et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male. 2015;18:5–11.
   PubMed Web of Science ®Google Scholar
• T'Sjoen G, Feyen E, De Kuyper P, et al. Self-referred patients in an aging male clinic: much more than androgen deficiency alone. Aging Male. 2003;6:157–165.
   PubMedGoogle Scholar
• Kelleher S, Conway AJ, Handelsman DJ. Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab. 2004;89:3813–3817.
   PubMed Web of Science ®Google Scholar
• Nguyen CP, Hirsch MS, Moeny D, et al. Testosterone and “age-related hypogonadism” – FDA concerns. N Engl J Med. 2015;373:689–691.
   PubMed Web of Science ®Google Scholar
• AACE Hypogonadism TF. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients—2002 update. Endocrine Pract. 2002;8:439–456.
   Google Scholar
• Huo S, Scialli AR, McGarvey S, et al. Treatment of men for “low testosterone”: a systematic review. PLoS One. 2016;11:e0162480.
   PubMed Web of Science ®Google Scholar
• Wells G, Elliott J, Kelly S, et al. Testosterone in the treatment of androgen deficiency. Ontario Drug Policy Research Network [Internet]. 2014 [cited 2017 Oct 8]. Available from: http://odprn.ca/wp-content/uploads/2014/12/114-TRT-systematic-review-final-Nov-17-2.pdf
   Google Scholar
• Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363:109–122.
   PubMed Web of Science ®Google Scholar
• Xu L, Freeman G, Cowling BL, et al. Testosterone therapy and cardiovascular events among men; a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med. 2013;11:108.
   PubMed Web of Science ®Google Scholar
• Alexander GC, Iyer G, Lucas E, et al. Cardiovascular risks of exogenous testosterone use among men: a systematic review and meta-analysis. Am J Med. 2017;130:293–305.
   PubMed Web of Science ®Google Scholar
• Calof OM, Singh AB, Lee ML, et al. Adverse events associated with testosterone replacement in middle-age and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci. 2005;60:1451–1457.
   PubMed Web of Science ®Google Scholar
• Haddad RM, Kennedy CC, Caples SM, et al. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc. 2007;82:29–39.
   PubMed Web of Science ®Google Scholar
• Fernandez-Balsells MM, Murad MH, Lane M, et al. Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2010;95:2560–2575.
   PubMed Web of Science ®Google Scholar
• Borst SE, Shuster JJ, Zou B, et al. Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis. BMC Med. 2014;12:211.
   PubMed Web of Science ®Google Scholar
• Corona G, Maseroli E, Rastrelli G, et al. Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert Opin Drug Saf. 2014;13:1327–1351.
   PubMed Web of Science ®Google Scholar
• Shores MM, Smith NL, Forsberg CW, et al. Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab. 2012;97:2050–2058.
   PubMed Web of Science ®Google Scholar
• Sharma R, Oni OA, Gupta K, et al. Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men. Eur Heart J. 2015;36:2706–2715.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. FDA drug safety communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use [Internet]. U.S. Food and Drug Administration [cited 2017 Aug 27]. Available from: https://www.fda.gov/Drugs/DrugSafety/ucm436259.htm
   Google Scholar
• Health Canada. Summary safety review – testosterone replacement products cardiovascular risk [Internet]. Health Canada; 2014 [cited 2017 Aug 27]. Available from: http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/testosterone-eng.php
   Google Scholar
• European Medicines Agency. No consistent evidence of an increased risk of heart problems with testosterone medicines [Internet]. European Medicine’s Agency [cited 2017 Aug 27]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2014/11/WC500177618.pdf
   Google Scholar
• Handelsman D. Global trends in testosterone prescribing, 2000-2011: expanding the spectrum of prescription drug misuse. Med J Aust. 2013;199:548–551.
   PubMed Web of Science ®Google Scholar
• Medlock S, Eslami S, Askari M, et al. Health information-seeking behavior of seniors who use the internet: A survey. J Med Internet Res. 2015;17:e10.
   PubMed Web of Science ®Google Scholar
• Jasuja GK, Bhasin S, Rose AJ. Patterns of testosterone prescription overuse. Curr Opin Endocrinol Diabetes Obes. 2017;24:240–245.
   PubMed Web of Science ®Google Scholar
• Atkinson NL, Saperstein SL, Pleis J. Using the internet for health-related activities: findings from a national probability sample. J Med Internet Res. 2009;11:e4.
   PubMed Web of Science ®Google Scholar
• Sullivan D. Google still world's most popular search engine by far, but share of unique searchers dips slightly [Internet]. Search engine land; 2013 [cited 2017 Sept 10]. Available from: http://searchengineland.com/google-worlds-most-popular-search-engine-148089
   Google Scholar
• iProspect. Search engine user behavior study: a report by iProspect and Jupiter Research [Internet]. [cited 2017 Sept 10]. Available from: http://district4.extension.ifas.ufl.edu/Tech/TechPubs/WhitePaper_2006_SearchEngineUserBehavior.pdf at: http://www.iprospect.com
   Google Scholar
• Morales A, Bebb RA, Manjoo P, et al. Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline. CMAJ. 2015;187:1369–1377.
   PubMed Web of Science ®Google Scholar
• Charnock D, editor. The DISCERN Handbook: Quality criteria for consumer health information on treatment choices [Internet]. Abingdon, U.K.: Radcliffe Medical Press; 1998 [cited 2017 Oct 6]. Available from: http://www.discern.org.uk/discern.pdf
   Google Scholar
• San Giorgi MRM, de Groot OSD, Dikkers FG. Quality and readability assessment of websites related to recurrent respiratory papillomatosis. Laryngoscope. 2017;127:2293–2297.
   PubMed Web of Science ®Google Scholar
• Hargrave DR, Hargrave UA, Bouffet E. Quality of health information on the Internet in pediatric neuro-oncology. Neuro Oncol. 2006;8:175–182.
   PubMed Web of Science ®Google Scholar
• Kincaid JP, Fishburne RP Jr, Rogers RL, et al. Derivation of new readability formulas (Automated Readability Index, Fog Count and Flesch Reading Ease Formula) for Navy-enlisted personnel. Research Branch Report 8-75, Millington, TN: Naval Technical Training, U.S. Naval Air Station; Memphis, TN; 1975.
   Google Scholar
• Flesch R. How to write plain English [Internet]. [cited 2017 Oct 3]. Available from: http://www.mang.canterbury.ac.nz/writing_guide/writing/flesch.shtml
   Google Scholar
• Busnelli A, Somigliana E, Vercellini P. “Forever young” – testosterone replacement therapy: a blockbuster drug despite flabby evidence and broken promises. Hum Reprod. 2017;32(4):719–724.
   PubMed Web of Science ®Google Scholar
• Layton JB, Kim Y, Alexander GC, et al. Association between direct-to-consumer advertising and testosterone testing and initiation in the United States, 2009-2013. J Am Med Assoc. 2017;317:1159–1166.
   PubMed Web of Science ®Google Scholar
• Kermode-Scott B. Canadian regulators dismiss complaint about campaign publicising low testosterone. BMJ. 2011;343:d5501.
   PubMed Web of Science ®Google Scholar
• Piszczek J, Mamdani M, Antoniou T, et al. The impact of drug reimbursement policy on rates of testosterone replacement therapy among older men. PLoS One. 2014;9:e98003.
   PubMed Web of Science ®Google Scholar
• Layton JB, Meier CR, Sharpless JL, et al. Comparative safety of testosterone dosage forms. JAMA Intern Med. 2015;175:1187.
   PubMed Web of Science ®Google Scholar
• Ravitch S, Fleisher L, Torres S. What websites are patients using: results of a tracking study exploring patients use of websites at a multi-media patient education center. AMIA Annu Symp Proc. 2005;2005:1092.
   Google Scholar
• Sillence E, Briggs P, Harris PR, et al. How do patients evaluate and make use of online health information? Soc Sci Med. 2007;64:1853–1862.
   PubMed Web of Science ®Google Scholar
• Sajid MS, Iftikhar M, Monteiro RS, et al. Internet information on colorectal cancer: commercialization and lack of quality control. Colorect Dis. 2008;10:352–356.
   PubMed Web of Science ®Google Scholar
• Pfizer Canada Inc. Depo-Testosterone Monograph [Internet]. [cited 2017 Sept 6]. Available from: https://www.pfizer.ca/sites/g/files/g10028126/f/201601/DepoTestosterone_PM_189981_15Jan2016_E.pdf
   Google Scholar
• McBride JA, Carson CC, Coward RM. Readability, credibility, and quality of patient information for hypogonadism and testosterone replacement therapy on the Internet. Int J Impot Res. 2017;29:110–114.
   PubMed Web of Science ®Google Scholar
• Oberlin DT, Masson P, Brannigan RE. Testosterone replacement therapy and the internet: an assessment of providers’ health-related web site information content. Urology. 2015;85:814–818.
   PubMed Web of Science ®Google Scholar
• Hiebert B, Leipert B, Regan S, et al. Rural mens health, health information seeking, and gender identities: a conceptual theoretical review of the literature. Am J Mens Health. 2016 [cited 2017 Oct 4]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27170674
   PubMed Web of Science ®Google Scholar
• Broom A. Virtually healthy: the impact of internet use on disease experience and the doctor-patient relationship. Qual Health Res. 2005;15:325–345.
   PubMed Web of Science ®Google Scholar
• Oh HJ, Lee B. The effect of computer-mediated social support in online communities on patient empowerment and doctor–patient communication. Health Commun. 2012;27:30–41.
   PubMed Web of Science ®Google Scholar
• Rosen RC, Seftel AD, Ruff DD, et al. A pilot study using a web survey to identify characteristics that influence hypogonadal men to initiate testosterone replacement therapy. Am J Mens Health. 2018;12:567–574.
   PubMed Web of Science ®Google Scholar
• Trinick TR, Feneley MR, Welford H, et al. International web survey shows high prevalence of symptomatic testosterone deficiency in men. Aging Male. 2011;14:10–15.
   PubMed Web of Science ®Google Scholar
• Weiss BD. Health literacy and patient safety: Help patients understand manual for clinicians Second edition. American Medical Association, American Medical Foundation. [cited 2017 Oct 3]. Available from: http://med.fsu.edu/userFiles/file/ahec_health_clinicians_manual.pdf
   Google Scholar
• National Institutes of Health. How to Write Easy-to-Read Health Materials. MedlinePlus [Internet]. [cited 2017 Oct 3]. Available from: https://medlineplus.gov/etr.html
   Google Scholar
• Doak CC, Doak LG, Friedell GH, et al. Improving comprehension for cancer patients with low literacy skills: strategies for clinicians. CA Cancer J Clin. 1998;48:151–162.
   PubMed Web of Science ®Google Scholar
• Doak CC, Doak LG, Root JH. Teaching patients with low literacy skills. 2nd ed. Philadelphia (PA): JB Lippincott; 1996.
   Google Scholar
• Ma Y, Yang AC, Duan Y, et al. Quality and readability of online information resources on insomnia. Front Med. 2017;11:423–431.
   PubMed Web of Science ®Google Scholar
• Yassin A, Nettleship JE, Talib RA, et al. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters. Aging Male. 2016;19:64–69.
   PubMed Web of Science ®Google Scholar